What’s the Preferred Method for Vincristine Administration When Treating a...
What is the preferred method to administer vincristine into a peripheral IV site when treating a patient with lymphoma or leukemia? A. Direct IV push by syringe B. By syringe through free-flowing IV...
View ArticleFDA Approves Epoetin Alfa-Epbx as a Biosimilar to Epoetin Alfa
On May 15, 2018, the U.S. Food and Drug Administration approved epoetin alfa-epbx (Retacrit™) as a biosimilar to epoetin alfa (Epogen/Procrit) for the treatment of anemia due to chronic kidney disease.
View ArticleHow Oncology Nurses Support Non-Oncology Units Administering Chemotherapy
Most patients and practitioners associate chemotherapy with cancer treatments, yet the drugs are also used to treat a number of autoimmune diseases, including multiple sclerosis, rheumatoid arthritis,...
View ArticleWhich RN Is Competent in Chemotherapy Administration?
Which RN is Competent in Chemotherapy Administration? One that took a chemotherapy course online 2 years ago and recently completed their annual education. One that witnessed a chemotherapy competent...
View ArticleONS Tackles Oral Chemotherapy Complexities
To ensure that patients and providers are equipped with the latest, most up-to-date knowledge and resources, ONS routinely works with patient advocacy groups, subject matter experts, and other provider...
View ArticleChemotherapy Is Still a Staple in Treatment Plans. Here’s a Fresh Look at a...
Despite all of the new drugs approved in recent years—particularly immunotherapies, oral agents, and biosimilars—that have forced nurses to consider many novel approaches to patient care, the...
View ArticleU.S. Spending on Antineoplastics Nearly Doubles From 2011–2016
Dollars spent on cancer drugs increased from $26.8 billion in 2011 to $42.1 billion in 2016, according to the results of a study reported in the Journal of Oncology Practice.
View ArticleHighly Emetogenic Chemotherapy Still Contributes to Potentially Avoidable...
The Centers for Medicare and Medicaid Services (CMS) implemented an oncology outcome measure to assess the quality of care and determine outpatient hospital payment (OP-35: Admissions and Emergency...
View ArticleAdding Chemo to Immunotherapy May Resensitize Resistant Tumors
Using chemotherapy with immune checkpoint inhibitors may reactivate tumors’ responses to immunotherapy, researchers concluded in a review article published in the Annals of Oncology.
View ArticleWhich of the Following Should Not Be Recommended to Patients Taking Oral...
Which of the Following Should Not Be Recommended to Patients Taking Oral Antineoplastic Medication at Home? A. Handwashing before and after handling the medication is important. B. Use a urinal or...
View ArticleThe Case of the Candy-Coated (Mis)Conception
P.G. is a 54-year-old woman who presents to the infusion center to receive her second cycle of chemotherapy for breast cancer. As her oncology nurse, you check the chemotherapy orders and patient...
View ArticleEducational Framework Offers Guidance for Oral Chemo Safety at Home
One aspect that ambulatory oncology nurses must consider in the greater staffing conversation is the time spent on educating patients and caregivers about oral chemotherapy safety in the home setting....
View ArticleDietary Supplements May Affect Breast Cancer Chemo Outcomes
Antioxidant supplements are associated with increased disease recurrence and statistically nonsignificant increased risk of mortality in patients with breast cancer who were receiving cyclophosphamide,...
View ArticlePolypharmacy Before Cancer Is Predictive of Post-Treatment Hospitalization
Patients who take five or more medications in the six months before beginning IV chemotherapy for a cancer diagnosis are more likely to be hospitalized after their chemotherapy treatment, according to...
View ArticleManage Immune-Related Adverse Events in Patients on Durvalumab
Durvalumab immunotherapy became a new standard of care for patients with stage III unresectable non-small cell lung cancer whose disease did not progress following two cycles of platinum-based...
View ArticleThe Case of the Terrible Taste
Tanya is a 46-year-old woman with leukemia. She recently finished induction therapy, and her oncologist told her she is ready to receive a hematopoietic stem cell transplant. You speak with Tanya about...
View ArticleAdding Nivolumab to Chemo Improves Survival for Advanced Gastric Cancer
First-line therapy combining nivolumab with chemotherapy improved median overall survival rates in patients with PD-L1-expressing gastric cancer by 3.3 months in a large international, multicenter...
View ArticleFDA Approves Trilaciclib to Reduce Chemotherapy-Induced Myelosuppression
On February 12, 2021, the U.S. Food and Drug Administration (FDA) approved trilaciclib (Cosela™) as the first therapy in its class to reduce the frequency of chemotherapy-induced myelosuppression in...
View ArticleAdding Chemo to Immunotherapy May Resensitize Resistant Tumors
Using chemotherapy with immune checkpoint inhibitors may reactivate tumors’ responses to immunotherapy, researchers concluded in a review article published in the Annals of Oncology.
View ArticleWhich of the Following Should Not Be Recommended to Patients Taking Oral...
Which of the Following Should Not Be Recommended to Patients Taking Oral Antineoplastic Medication at Home? A. Handwashing before and after handling the medication is important. B. Use a urinal or...
View Article
